Fig. 17
From: In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents
Binding mode of five most active compounds (16, 12, N9, W20 and Z24) into the 3ERT active site
Fig. 17 | BMC Chemistry